{"id":409876,"date":"2021-01-06T16:13:22","date_gmt":"2021-01-06T21:13:22","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=409876"},"modified":"2021-01-06T16:13:22","modified_gmt":"2021-01-06T21:13:22","slug":"genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\/","title":{"rendered":"GENFIT to Present at Upcoming Investor Conferences and Host a PBC KOL Event"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">\n        <strong>Lille, France; Cambridge, MA; January 6, 2021<\/strong> &#8211; <strong>GENFIT (Nasdaq and Euronext: GNFT)<\/strong>, a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and liver diseases<strong>, <\/strong>today announced that it will be presenting at the following upcoming investor conferences and host a Primary Biliary Cholangitis (PBC) KOL event for the financial community. <\/p>\n<p align=\"justify\">\n        <strong>Investor Conferences<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li>Oddo 24<sup>th<\/sup> BHF Forum, January 7 &#8211; 8, 2021;<\/li>\n<li>Solebury Trout Management Access Event, January 6 \u2013 15, 2021;<\/li>\n<li>Invest Securities Biomed Event, January 26 &#8211; 27, 2021;<\/li>\n<li>Leerink Annual Global Healthcare Conference, February 23 &#8211; 25, 2021.<\/li>\n<\/ul>\n<p align=\"justify\">\n        <strong>PBC KOL EVENT for the financial community<\/strong>\n      <\/p>\n<p align=\"justify\">GENFIT will host a KOL event on Primary Biliary Cholangitis (PBC), the main indication for its lead product elafibranor, a dual PPAR a\/d agonist. The event will feature presentations from GENFIT senior management and KOLs engaged in the management of PBC patients. The program will focus on the PBC treatment landscape, the utilization of elafibranor in PBC, and the PBC commercial opportunity. Two sessions will be organized, one in English and one in French. The event dates will be communicated shortly, and information will be available on the investor page of GENFIT\u2019s corporate website, under the events section, at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uKKkxAF85fXktUHi2XZ4Y1O_T6ptO2kw5z2kvNjZe7jCDWouElLh3dq8JtDKwYizgjm8UwsYbO5CBagPzR4G58g6pg1r6l0iblK8XCn__Ys=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/ir.genfit.com<\/a>. <\/p>\n<p align=\"justify\">\n        <strong>ABOUT GENFIT<\/strong>\n      <\/p>\n<p align=\"justify\">GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with cholestatic and metabolic chronic liver diseases. GENFIT is a pioneer in the field of nuclear receptor-based drug discovery, with a rich history and strong scientific heritage spanning more than two decades. GENFIT is currently enrolling in ELATIVE\u2122, a Phase 3 clinical trial evaluating elafibranor in patients with Primary Biliary Cholangitis (PBC). As part of GENFIT\u2019s comprehensive approach to clinical management of patients with liver disease, the Company is also developing NIS4\u2122, a new, non-invasive blood-based diagnostic technology which could enable easier identification of patients with at-risk NASH.\u00a0 NIS4\u2122 technology has been licensed to LabCorp in the U.S. and Canada for the development and commercialization of a blood-based molecular diagnostic test powered by NIS4\u2122 technology. GENFIT has facilities in Lille and Paris, France, and Cambridge, MA, USA. GENFIT is a publicly traded company listed on the Nasdaq Global Select Market and on compartment B of Euronext\u2019s regulated market in Paris (Nasdaq and Euronext: GNFT). <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GR2ljfBKQ2nvYXN9cJhREurTl-YNixbPlV8OQw00nIemLerwUvLW1Mjlh4h5Jc1jDvTKHhMSzjvIOiFT4Put8A==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.genfit.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>CONTACT<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>GENFIT<\/strong> | Investors<\/p>\n<p align=\"justify\">Naomi EICHENBAUM \u2013 Investor Relations | Tel: +1 (617) 714 5252 | <u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=arura9SWZ-puWM5CY6jacq7D060e5J6MVLYQA2YBzqwvJbreGOl5r9KgNvgjnIudLfrJmHJFmiix3MasTCBJmcvLUmArTPD4_KlKfFkQuvM=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">investors@genfit.com<\/a><\/u><\/p>\n<p align=\"justify\">\n        <strong>PRESS RELATIONS <\/strong>| Media<\/p>\n<p align=\"justify\">H\u00e9l\u00e8ne LAVIN \u2013 Press relations | Tel: +333 2016 4000 | <u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=suevK5o4NwbmRNL1FONAmnzvdDBBeywJUUlurjhDuEAtW3PnRFK7CWMohzPyibrLO6BH184mmNOdfxGfoHKFTp4jhWXb0muaQ3NkTDxkG7Y=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">helene.lavin@genfit.com<\/a><\/u><\/p>\n<p>\u00a0 <strong>GENFIT<\/strong> | 885 Avenue Eug\u00e8ne Avin\u00e9e, 59120 Loos &#8211; FRANCE | +333 2016 4000 | www.genfit.com\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0  <\/p>\n<p \/>\n<p id=\"gnw_attachments_section-header\">\n        <strong>Attachment<\/strong>\n      <\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>\n          <a target=\"_blank\" href=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/7508efdf-3ffb-4709-a078-7ca29daa7da5\" rel=\"noopener noreferrer\">GENFIT to Present at Upcoming Investor Conferences and Host a PBC KOL Event <\/a>\n        <\/li>\n<\/ul>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0OTM4NyM0MDA4NDgxNjUjMTAxMTI2OA==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml-eu.globenewswire.com\/release\/track\/56e4aaa5-7b0c-4159-a748-06eb7545ffda\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Lille, France; Cambridge, MA; January 6, 2021 &#8211; GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and liver diseases, today announced that it will be presenting at the following upcoming investor conferences and host a Primary Biliary Cholangitis (PBC) KOL event for the financial community. Investor Conferences Oddo 24th BHF Forum, January 7 &#8211; 8, 2021; Solebury Trout Management Access Event, January 6 \u2013 15, 2021; Invest Securities Biomed Event, January 26 &#8211; 27, 2021; Leerink Annual Global Healthcare Conference, February 23 &#8211; 25, 2021. PBC KOL EVENT for the financial community GENFIT will host a KOL event on Primary Biliary Cholangitis (PBC), the main indication for its lead product &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;GENFIT to Present at Upcoming Investor Conferences and Host a PBC KOL Event&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-409876","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GENFIT to Present at Upcoming Investor Conferences and Host a PBC KOL Event - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GENFIT to Present at Upcoming Investor Conferences and Host a PBC KOL Event - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Lille, France; Cambridge, MA; January 6, 2021 &#8211; GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and liver diseases, today announced that it will be presenting at the following upcoming investor conferences and host a Primary Biliary Cholangitis (PBC) KOL event for the financial community. Investor Conferences Oddo 24th BHF Forum, January 7 &#8211; 8, 2021; Solebury Trout Management Access Event, January 6 \u2013 15, 2021; Invest Securities Biomed Event, January 26 &#8211; 27, 2021; Leerink Annual Global Healthcare Conference, February 23 &#8211; 25, 2021. PBC KOL EVENT for the financial community GENFIT will host a KOL event on Primary Biliary Cholangitis (PBC), the main indication for its lead product &hellip; Continue reading &quot;GENFIT to Present at Upcoming Investor Conferences and Host a PBC KOL Event&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-06T21:13:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0OTM4NyM0MDA4NDgxNjUjMTAxMTI2OA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"GENFIT to Present at Upcoming Investor Conferences and Host a PBC KOL Event\",\"datePublished\":\"2021-01-06T21:13:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\\\/\"},\"wordCount\":430,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ0OTM4NyM0MDA4NDgxNjUjMTAxMTI2OA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\\\/\",\"name\":\"GENFIT to Present at Upcoming Investor Conferences and Host a PBC KOL Event - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ0OTM4NyM0MDA4NDgxNjUjMTAxMTI2OA==\",\"datePublished\":\"2021-01-06T21:13:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ0OTM4NyM0MDA4NDgxNjUjMTAxMTI2OA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ0OTM4NyM0MDA4NDgxNjUjMTAxMTI2OA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GENFIT to Present at Upcoming Investor Conferences and Host a PBC KOL Event\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GENFIT to Present at Upcoming Investor Conferences and Host a PBC KOL Event - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\/","og_locale":"en_US","og_type":"article","og_title":"GENFIT to Present at Upcoming Investor Conferences and Host a PBC KOL Event - Market Newsdesk","og_description":"Lille, France; Cambridge, MA; January 6, 2021 &#8211; GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and liver diseases, today announced that it will be presenting at the following upcoming investor conferences and host a Primary Biliary Cholangitis (PBC) KOL event for the financial community. Investor Conferences Oddo 24th BHF Forum, January 7 &#8211; 8, 2021; Solebury Trout Management Access Event, January 6 \u2013 15, 2021; Invest Securities Biomed Event, January 26 &#8211; 27, 2021; Leerink Annual Global Healthcare Conference, February 23 &#8211; 25, 2021. PBC KOL EVENT for the financial community GENFIT will host a KOL event on Primary Biliary Cholangitis (PBC), the main indication for its lead product &hellip; Continue reading \"GENFIT to Present at Upcoming Investor Conferences and Host a PBC KOL Event\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-06T21:13:22+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0OTM4NyM0MDA4NDgxNjUjMTAxMTI2OA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"GENFIT to Present at Upcoming Investor Conferences and Host a PBC KOL Event","datePublished":"2021-01-06T21:13:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\/"},"wordCount":430,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0OTM4NyM0MDA4NDgxNjUjMTAxMTI2OA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\/","name":"GENFIT to Present at Upcoming Investor Conferences and Host a PBC KOL Event - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0OTM4NyM0MDA4NDgxNjUjMTAxMTI2OA==","datePublished":"2021-01-06T21:13:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0OTM4NyM0MDA4NDgxNjUjMTAxMTI2OA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0OTM4NyM0MDA4NDgxNjUjMTAxMTI2OA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genfit-to-present-at-upcoming-investor-conferences-and-host-a-pbc-kol-event\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"GENFIT to Present at Upcoming Investor Conferences and Host a PBC KOL Event"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/409876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=409876"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/409876\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=409876"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=409876"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=409876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}